Several major strengths of this study lie in the inclusion of relatively strict statistical screening and adjustment parameters, the adoption of a longitudinal cohort design, the relatively large sample size, the exploration of the nonlinear association between ALT/AST ratio and NAFLD risk and the performance of a hierarchical analysis. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.